Literature DB >> 23175241

Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.

Do Nyun Kim1, Min Koo Seo1, Hoyun Choi1, Su Yeon Kim1, Hee Jong Shin1, A-Ran Yoon1, Qian Tao2, Sun Young Rha3, Suk Kyeong Lee1.   

Abstract

Epstein-Barr virus (EBV) is a herpesvirus associated with lymphomas and carcinomas. While EBV-associated epithelial cell lines are good model systems to investigate the role of EBV in carcinoma, only a few cell lines are available as they are hard to acquire. A greater variety of naturally EBV-infected cell lines which are derived from tumour patients are needed to represent various features of EBVaGC. We characterized cell line YCCEL1, established from a Korean EBVaGC patient, to ascertain whether it can be used to study the roles of EBV in EBVaGC. The expression of EBV genes and cell surface markers was examined by in situ hybridization, RT-PCR, Western blot analysis, immunofluorescence assay and Northern blot analysis. EBV episomal status was analysed by Southern blotting and real-time PCR. This cell line expressed EBV nuclear antigen 1 (EBNA1) and latent membrane protein 2A (LMP2A), but not EBNA2, LMP2B nor LMP1. The majority of the lytic proteins were not detected in YCCEL1 cells either before or after treatment with 12-O-tetradecanoylphorbol-13-acetate. YCCEL1 cells expressed BART microRNAs (miRNAs) at high level but did not express BHRF1 miRNAs. YCCEL1 cells expressed cytokeratin, but not CD21 and CD19, suggesting CD21-independent EBV infection. The latent EBV gene and EBV miRNA expression pattern of YCCEL1 cells closely resembled that of general EBVaGC cases. Our results support the value of YCCEL1 cells as a good model system to study the role of EBV in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175241     DOI: 10.1099/vir.0.045237-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.

Authors:  Michael J Strong; Thomas Laskow; Hani Nakhoul; Eugene Blanchard; Yaozhong Liu; Xia Wang; Melody Baddoo; Zhen Lin; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Investigation on the association between thyroid tumorigeneses and herpesviruses.

Authors:  J F M Almeida; A H Campos; M A Marcello; N E Bufalo; C L Rossi; L H P Amaral; A B Marques; L L Cunha; C A Alvarenga; P C Tincani; A J Tincani; L S Ward
Journal:  J Endocrinol Invest       Date:  2017-03-08       Impact factor: 4.256

3.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 4.  Phylogenetic comparison of Epstein-Barr virus genomes.

Authors:  Su Jin Choi; Seok Won Jung; Sora Huh; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

5.  Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Authors:  Aya Shinozaki-Ushiku; Akiko Kunita; Maya Isogai; Takashi Hibiya; Tetsuo Ushiku; Kenzo Takada; Masashi Fukayama
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.

Authors:  Teru Kanda; Yuki Furuse; Hitoshi Oshitani; Tohru Kiyono
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

7.  Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.

Authors:  Hyoji Kim; Hoyun Choi; Suk Kyeong Lee
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

8.  Extracellular Vesicles in Epstein-Barr Virus Pathogenesis.

Authors:  Allaura S Cone; Sara B York; David G Meckes
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-03

9.  EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.

Authors:  Samantha S Soldan; Emma M Anderson; Drew M Frase; Yue Zhang; Lisa B Caruso; Yin Wang; Julianna S Deakyne; Benjamin E Gewurz; Italo Tempera; Paul M Lieberman; Troy E Messick
Journal:  Gastric Cancer       Date:  2021-04-30       Impact factor: 7.701

10.  Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Authors:  Huang Kie Kyon; Arnoud Boot; Nisha Padmanabhan; Kevin Lim; Supriya Srivastava; Shuwen Chen; Zhiyuan Wu; Hyung-Ok Lee; Vineeth T Mukundan; Charlene Chan; Yarn Kit Chan; Ong Xuewen; Jason J Pitt; Zul Fazreen Adam Isa; Manjie Xing; Ming Hui Lee; Angie Lay Keng Tan; Shamaine Ho Wei Ting; Micah A Luftig; Dennis Kappei; Warren D Kruger; Jinsong Bian; Ying Swan Ho; Ming Teh; Steve George Rozen; Patrick Tan
Journal:  Genome Biol       Date:  2021-06-01       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.